Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Farmakol Toksikol ; 51(1): 12-4, 1988.
Article in Russian | MEDLINE | ID: mdl-2896131

ABSTRACT

Four new derivatives of glutamic and gamma-aminobutyric acids influencing the central nervous system were produced. By the character of their action they refer to the substances of the sedating tranquilizing type without the myorelaxant component. The drug activity degree depends on its ability to penetrate through cell membranes that is in turn determined by the structure of the compound.


Subject(s)
Glutamates/pharmacology , Nicotinic Acids/pharmacology , Psychotropic Drugs/pharmacology , gamma-Aminobutyric Acid/analogs & derivatives , Animals , Cell Membrane Permeability/drug effects , Dose-Response Relationship, Drug , Glutamic Acid , Mice , Motor Activity/drug effects , Structure-Activity Relationship , gamma-Aminobutyric Acid/pharmacology
2.
Farmakol Toksikol ; 48(5): 51-5, 1985.
Article in Russian | MEDLINE | ID: mdl-2934271

ABSTRACT

Experiments on 75 dogs with experimental myocardial infarction were made to study and compare the therapeutic effect of nicamag (a mixture of potassium and magnesium nicotinates) in a dose of 10 mg/kg, panangin and asparkam (potassium and magnesium aspartates). Nicamag rapidly precipitated postinfarction arrhythmia and made the ECG completely return to normal in the majority of cases. A beneficial effect of the drug on carbohydrate, energy and electrolyte metabolism in the myocardium was discovered to underlie the above-described action. Nicamag abruptly lowered the titers of cardial antibodies, increased the fibrinalytic activity of the blood which is accounted for by the effect of the anion--nicotinic acid.


Subject(s)
Aspartic Acid/analogs & derivatives , Myocardial Infarction/drug therapy , Potassium Magnesium Aspartate/analogs & derivatives , Potassium Magnesium Aspartate/therapeutic use , Vasodilator Agents/therapeutic use , Adenosine Triphosphatases/metabolism , Adenosine Triphosphate/metabolism , Animals , Dogs , Drug Combinations , Energy Metabolism , Lactates/metabolism , Lactic Acid , Myocardium/metabolism , Pyruvates/metabolism , Pyruvic Acid
3.
Farmakol Toksikol ; 42(5): 501-4, 1979.
Article in Russian | MEDLINE | ID: mdl-488322

ABSTRACT

It has been shown in rat experimental aconitinic arrhythmia and in dog postinfarction arrhythmia that combined potassium and magnesium nicotinates show a pronounced anti-arrhythmic effect. The studies on the drug distribution in the tissues indicate that the content of potassium, magnesium and total coenzymatic forms of nicotinic acid rises in the myocardium by the 12th hour from the commencement of the drug administration. Intracellular and exocellular content of potassium and sodium has been shown to return to normal.


Subject(s)
Anti-Arrhythmia Agents , Magnesium/therapeutic use , Nicotinic Acids/therapeutic use , Potassium/therapeutic use , Animals , Arrhythmias, Cardiac/drug therapy , Dogs , Drug Combinations , Drug Evaluation, Preclinical , Kinetics , Magnesium/metabolism , Myocardial Infarction/drug therapy , Nicotinic Acids/metabolism , Potassium/metabolism , Rats , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...